Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Belimumab effectively controls SLE disease activity and reduces steroid use.

New compounds may help treat prostate cancer by reducing cell growth.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

A(1-7) treatment reduces symptoms of lupus in mice.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Spironolactone may help women with hidradenitis suppurativa.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.